Knight Cardiovascular Institute

Medicine & Life Sciences

1. Echocardiography 100%
2. Sheep 95%
3. Heart Diseases 89%
4. Heart 80%
5. Heart Failure 78%
6. Cardiovascular Diseases 76%
7. Fetus 76%
8. Placenta 74%
9. Sudden Cardiac Death 73%
10. Electrocardiography 71%
11. Atherosclerosis 68%
12. Microbubbles 67%
13. Coronary Artery Disease 62%
14. Chest Pain 60%
15. Perfusion 58%
16. Blood Platelets 56%
17. Pregnancy 55%
18. Myocardial Infarction 54%
19. Mothers 53%
20. Molecular Imaging 51%
21. Implantable Defibrillators 50%
22. Acute Coronary Syndrome 49%
23. Lipids 49%
24. Therapeutics 47%
25. LDL Cholesterol 47%
26. Hyperlipoproteinemia Type II 47%
27. Computed Tomography Angiography 46%
28. Cardiac Arrhythmias 45%
29. Cardiac Myocytes 44%
30. Proprotein Convertase 9 42%
31. Hypertrophic Cardiomyopathy 41%
32. Blood Vessels 40%
33. Stroke Volume 40%
34. Hemodynamics 40%
35. Hydroxymethylglutaryl-CoA Reductase Inhibitors 39%
36. Mortality 36%
37. Growth 36%
38. Confidence Intervals 36%
39. Pressure 35%
40. Cardiomyopathies 35%
41. Atrial Fibrillation 34%
42. Fetal Development 33%
43. Equipment and Supplies 33%
44. Tomography 33%
45. Genes 33%
46. Registries 31%
47. Cardiology 31%
48. Blood Volume 31%
49. Lipoproteins 30%
50. Lead 30%
51. Arterial Pressure 30%
52. Blood Pressure 28%
53. Health 28%
54. Cholesterol 28%
55. Mutation 27%
56. Multicenter Studies 27%
57. Hypertension 27%
58. Adenosine 27%
59. Contrast Media 26%
60. Transcatheter Aortic Valve Replacement 26%
61. Population 26%
62. Hospital Emergency Service 26%
63. Heart Ventricles 26%
64. Parturition 26%
65. Ischemia 26%
66. Diet 26%
67. Heart-Assist Devices 26%
68. Bicuspid Aortic Valve 26%
69. Proteins 26%
70. Ghrelin 25%
71. Exercise 25%
72. Insulin 25%
73. 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid 25%
74. Stroke 24%
75. Insulin Resistance 24%
76. Fats 24%
77. Myocardial Ischemia 24%
78. Guidelines 24%
79. Obesity 24%
80. Triglycerides 24%
81. Troponin 24%
82. Phenotype 24%
83. Randomized Controlled Trials 24%
84. LDL Receptors 24%
85. Glucose 24%
86. Placebos 23%
87. Pathologic Constriction 23%
88. Ultrasonography 23%
89. Oxygen 23%
90. Myocardium 23%
91. Angiography 23%
92. Safety 22%
93. Amyloidosis, Hereditary, Transthyretin-Related 22%
94. Lipoprotein(a) 22%
95. Thrombosis 22%
96. Infarction 22%
97. Swine 22%